Selective publication bias in top psychiatry journals was not explained by the quality of the studies, but by financial ties to pharma.
Researchers find that SSRIs increase suicide attempts up to age 24, and have no preventative effect at any age, even for those at high risk of suicide.
For those with severe depression, inpatient CBT was effective but the adding antidepressants did not improve treatment outcomes.
Antidepressant users share their frustrations towards a healthcare system that overprescribes but is ill-equipped to support with discontinuation and withdrawal symptoms.
In a study of people with borderline personality disorder, only ADHD stimulants were associated with a decrease in suicide.
Moncrieff et al. respond to the contradictory and, in some cases, false concerns raised by these critics of their serotonin review.
Genetic testing may help reduce the length of time people experience the harmful effects of antidepressant drugs, but it is not helpful for predicting efficacy.
World Psychiatry article challenges conventional antidepressant prescription practices.
A new Cochrane review details the lack of evidence for antidepressants in the treatment of chronic pain.
Study reveals most patients are dissatisfied with prescribers' support when discontinuing antidepressants.
New study finds polypharmacy for 73% of older adults on antidepressants, with 56% at risk of harmful drug interactions.
Growing rates of long-term psychiatric drug prescriptions and documented issues with withdrawal demonstrate a need for safe deprescribing practices.
Leading figures in psychiatry acknowledge that DSM psychiatric diagnoses and the chemical imbalance theory of mental illness are not scientifically valid, but are useful fictions that help people manage their emotions and comply with their medication treatments.
Researchers suggest that antidepressant withdrawal can be a possible precipitant of suicide.
A study finds that commonly prescribed antidepressants are associated with the development of diabetes, hypertension, and other diseases.
We talk with author Beverley Thomson about her latest book, entitled Antidepressed: A Breakthrough Examination of Epidemic Antidepressant Harm and Dependence.
Peter Simons covers in detail a new systematic review that debunks the widely popularized myth of low serotonin in depression, the “chemical imbalance theory.”
Researchers found that 25% of elderly patients taking antidepressants had serotonin syndrome, which is potentially life-threatening.
Peter Simons covers news on mental health app Cerebral and pharma companies Biogen and Cassava; how social media influencers are the new pharma marketers; studies that found antidepressants don't improve quality of life and are harmful to the fetus when pregnant women take them; benzo withdrawal; and more!
The problems related to the use of antidepressants cannot be solved by an oversimplified psychiatry brainwashed by the pharmaceutical industry.
Peter Simons covers a paper arguing that “psychology is fundamentally incompatible with hypothesis-driven theoretical science,” another paper finding that evidence-based medicine is more corporate gimmick than reliable science, a study that found psychiatrists deliver the worst-quality healthcare of any medical specialty, and more!
Mark Horowitz and David Taylor provide advice on how to tell the difference between antidepressant withdrawal and depression relapse.
According to patient reports, SSRI antidepressants most frequently lead to the subjective experience of emotional blunting.